Kukkonen K, Afyounian E, Rauhala H, Nykter M, Urbanucci A, Latonen L, Visakorpi T (2026)
Androgen receptor drives divergent chromatin accessibility programs in benign and malignant prostate epithelial cells
Nucleic Acids Res, 54 (17)
DOI 10.1093/nar/gkag891, PubMed 42745664

Sivanesan S, Ramberg H, Kristiansen T, Thapa SB, Bjøre M, Berge V, Ottosson F, Brennhovd B, Storås AMH, Thorsby PM, Dahl SR, Urbanucci A, Grytli HH, Bjerke L, Taskén KA (2026)
Perioperative propranolol during robotic-assisted radical prostatectomy: A randomised, double-blind, placebo-controlled, pilot trial (PeP-RALP)
BJUI Compass, 7 (9), e70267
DOI 10.1002/bco2.70267, PubMed 42662047

Doultsinos D, Tomljanovic I, Pilalis E, Abusamra SM, Alshalalfa M, Parmentier R, Ahire V, Bridges IE, Figiel S, Hester J, Leach D, Nandakumar A, Wan R, Zekri Y, Zhang J, Bevan CL, O'Neill E, Lamb AD, Macauley V, Theurillat JP, Urbanucci A, Karnes RJ, Spratt DE, Davicioni E, Quigley D, Zwart W, Le Magnen C, Chatziioannou A, Mills IG (2026)
IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states
EMBO Mol Med (in press)
DOI 10.1038/s44321-026-00490-w, PubMed 42632837